Study design
LONG COVID
This study is an open-label randomized clinical trial (RCT) using two parallel groups of Long COVID patients. The first group follows the TAU methods established by the primary health care GP (control group) and the second follows the TAU methods and also uses the APP ReCOVery, as a coadjutant treatment in their recovery (intervention group). In addition, the intervention group attend three face-to-face sessions based on motivational methodology and APP management, with the aim of promoting adherence to the APP. Table Template for intervention description and replication (TIDieR) checklist.This RCT was registered in the ISRCTN Registry platform (Registry No.: ISRCTN91104012) on 10/02/2022. The original study protocol specifies multiple methodological aspects and has recently been published